A
ABUS
Arbutus Biopharm
4.350
-0.090-2.03%After Hours: 4.477 +0.127 +2.91%18:26 05/22 EDT
OPEN/PREV CLOSE4.440/4.440
TODAY RANGE4.330-4.530
VOL847.36K
MARKET CAP859.29M
52 WEEK RANGE3.040-5.10
AVG VOL (3M)2.15M
% TURNOVER0.43%
TURNOVER--
P/E (TTM)5.29
% RANGE4.50%
EPS(TTM)0.8225
P/E(FORWARD)5.84
P/B3.293
BVPS1.321
DIVIDEND--
P/S59.51
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP683.27M
SHARES OUTSTANDING197.54M
NEXT EARNINGS08/04-08/10
FREE FLOAT157.07M
LOT SIZE1
EX-DATE11/04/2010
News
Press Releases
Financial Reports
Profile
Reuters·05/13 11:42
Arbutus Biopharma Q1 revenue surges on Moderna settlement
Seeking Alpha·05/13 11:32
Arbutus Biopharma GAAP EPS of $0.87, revenue of $179.1M
Dow Jones·05/13 11:30
*Arbutus Biopharma 1Q Net $169.7M >ABUS
Dow Jones·05/13 11:30
*Arbutus Biopharma 1Q Rev $179.1M >ABUS
Dow Jones·05/13 11:30
*Arbutus Biopharma 1Q EPS 87c >ABUS
Seeking Alpha·05/13 09:41
Arbutus Biopharma: A Fascinating HBV Story, But Still Too Early
Barchart·05/13 06:36
Arbutus: Q1 Earnings Snapshot
Benzinga·04/21 17:58
Europe Clears First Flu/COVID Combo Shot From Moderna
Barchart·04/20 05:55
Moderna's Quarterly Earnings Preview: What You Need to Know
Benzinga·04/16 12:03
QuidelOrtho, MIND Technology, Southern First Bancshares And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Benzinga·04/16 09:28
Why J B Hunt Transport Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Reuters·04/15 16:12
BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financial, Papa John's
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.